Research Progress on the Integrated Traditional Chinese and Western Medicine Treatment of Lower Extremity Arteriosclerosis Obliterans

Lower extremity arteriosclerosis obliterans (LEASO), as a chronic vascular disease with a relatively high disability rate, the optimization of its treatment strategies has always been a hot topic in clinical research. Modern medicine achieves revascularization through methods such as antiplatelet aggregation (such as the dual anti-thrombotic regimen), endovascular intervention (the patency rate of stent implantation reaches 92.3%), and open surgery. Traditional Chinese medicine, based on the theory of “deficiency of the root and excess of the superficiality”, adopts internal administration of traditional Chinese medicine (such as Huiyang Tongmai Decoction, which can improve the ABI value by 0.23±0.05), external application of ointments (promoting the removal of pus and decay to accelerate wound healing), and acupuncture therapy (increasing the painless claudication distance by 42.3%) for overall conditioning. Clinical practice has confirmed that the integrated traditional Chinese and Western medicine treatment can significantly increase the vascular patency rate to 94.6% at 3 months after surgery (P<0.05), providing a better solution for the treatment of LEASO.